Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Jan 2010 07:00 AM
RNS
The ICR, Sareum and CRT Limit
16 Dec 2009 11:01 AM
RNS
Result of AGM
04 Dec 2009 03:18 PM
RNS
Issue of options
24 Nov 2009 05:05 PM
RNS
Holding(s) in Company
20 Nov 2009 07:00 AM
RNS
Availability of Report & Acco
02 Nov 2009 07:00 AM
RNS
Sareum to Present at BIO-Euro
30 Oct 2009 07:00 AM
RNS
Total Voting Rights
27 Oct 2009 07:00 AM
RNS
Final Results
19 Oct 2009 02:49 PM
RNS
Holding(s) in Company
19 Oct 2009 07:00 AM
RNS
NOMAD - change of name
15 Oct 2009 09:52 AM
RNS
Holding(s) in Company
12 Oct 2009 05:02 PM
RNS
Issue of Equity
12 Oct 2009 07:00 AM
RNS
Issue of Equity
09 Oct 2009 04:11 PM
RNS
Holding(s) in Company
08 Oct 2009 07:00 AM
RNS
Holding(s) in Company
06 Oct 2009 07:00 AM
RNS
Cancer Research Programme to
30 Sep 2009 07:00 AM
RNS
Total Voting Rights
21 Sep 2009 07:00 AM
RNS
Holding(s) in Company
16 Sep 2009 04:15 PM
RNS
Holding(s) in Company
10 Sep 2009 07:00 AM
RNS
Holding(s) in Company
08 Sep 2009 07:00 AM
RNS
Issue of Equity
03 Sep 2009 10:57 AM
RNS
Holding(s) in Company
28 Aug 2009 12:57 PM
RNS
Statement re Share Price Move
05 Jun 2009 10:53 AM
RNS
Statement re. Bulletin Board
24 Apr 2009 11:03 AM
RNS
Holding(s) in Company
20 Apr 2009 01:22 PM
RNS
Holding(s) in Company
23 Mar 2009 03:08 PM
RNS
Holding(s) in Company
23 Mar 2009 12:56 PM
RNS
Statement re share price move
23 Feb 2009 07:00 AM
RNS
Half Yearly Report
13 Feb 2009 04:23 PM
RNS
Holding(s) in Company
27 Jan 2009 10:46 AM
RNS
Result of AGM
13 Jan 2009 12:30 PM
RNS
Change of Registered Office
22 Dec 2008 02:47 PM
RNS
Publication of Report & Accou
22 Dec 2008 07:29 AM
RNS
Restoration of Listing
27 Nov 2008 02:44 PM
RNS
Final Results
16 Sep 2008 11:45 AM
RNS
End of Offer Period
29 Aug 2008 01:56 PM
RNS
Directorate Change and Update
26 Aug 2008 07:00 AM
RNS
Disposal
11 Jul 2008 05:59 PM
RNS
Directorate Change
09 Jul 2008 03:45 PM
RNS
Statement re. Suspension
01 Jul 2008 04:39 PM
RNS
Directorate Change
26 Jun 2008 12:27 PM
RNS
Change of Broker
25 Jun 2008 07:00 AM
RNS
Three Repeat Business Agreeme
19 Jun 2008 07:00 AM
RNS
Corporate update
14 May 2008 07:00 AM
RNS
Restructuring
02 May 2008 07:01 AM
RNS
Strategic Review
24 Apr 2008 11:07 AM
RNS
Notification of Shareholder
14 Apr 2008 09:26 AM
RNS
Fundraising
10 Apr 2008 07:01 AM
RNS
Presentation at AACR
31 Mar 2008 07:00 AM
RNS
Extension of Collaboration

Sareum Holdings Plc (Sareum) is a clinical-stage drug discovery and development company that produces targeted small-molecule therapeutics for treating cancer and autoimmune diseases.

The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor Library (SKIL). The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. Its research programs include Chk1 (checkpoint kinase 1), Aurora+FLT3 kinase, Autoimmune-TYK2/JAK1 kinases, and Cancer-TYK2/JAK1 kinases. Sareum's Chk1 kinase cancer research program is being conducted through joint research collaboration with Cancer Research Technology Limited and the Institute of Cancer Research. Sareum is headquartered in Cambridge, the UK.

SAR share price listed on AIM in 2004 under the ticker SAR.

UK 100

Latest directors dealings